http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104707173-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-24 |
| filingDate | 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104707173-B |
| titleOfInvention | A kind of Three-dimensional cell culture platform, its preparation method and its using method |
| abstract | The embodiment of the invention discloses a kind of Three-dimensional cell culture platform, its preparation method and its using method.Wherein, Three-dimensional cell culture platform includes：Skeletonization support, PLGA sustained-release micro-spheres, insulin；The skeletonization support is network structure, the PLGA sustained-release micro-spheres are attached on the skeletonization support, the insulin is wrapped in the PLGA sustained-release micro-spheres, based on the gross mass of the Three-dimensional cell culture platform, the mass fraction of the insulin is 0.5 ‰～5 ‰.When carrying out BMSCs cultures using the Three-dimensional cell culture platform, the cell viability of BMSCs, the expression of osteogenic factor are significantly higher than the conventional materials such as hydroxyapatite, therefore can realize persistently promoting BMSCs Osteoblast Differentiation. |
| priorityDate | 2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 175.